Bregje Christiaenssen

Bregje Christiaenssen

Auto-generated profile, based on publicly available information

Bregje Christiaenssen

Cell Death Signaling Laboratory, Department of Biomedical Sciences, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2026 in Cell Death & Differentiation
Verified
Journal Article
Open access
BCBregje Christiaenssen
Bregje Christiaenssen
SMSilke Mortelmans
Silke Mortelmans
SBSiham Baghli
Siham Baghli
FBFleur Boone
Fleur Boone
WXWei Xie
Wei Xie
AWAndy Wullaert
Andy Wullaert
Cryopyrin-associated periodic syndromes (CAPS) are autoinflammatory disorders caused by gain-of-function NLRP3 variants. Although NLRP3 inflammasomes mediate IL-1β secretion through Gasdermin D (GSDMD), we show that GSDMD deletion did not prevent autoinflammation in mice ubiquitously expressing the Nlrp3 A350V variant. Inflamed skin of Nlrp3 A350V -expressing GSDMD-deficient mice displayed citrullinated histone 3-containing neutrophil extracellular traps (CitH3-NETs). CitH3-NETs induced IL-1β secretion from murine Nlrp3 A350V -expressing GSDMD-deficient macrophages as well as from human CAPS patient monocytes and macrophages. Blocking protein arginine deiminase-4 (PAD4) prevented CitH3 release and disabled the IL-1β-inducing NET effects, identifying CitH3 as crucial trigger. Mechanistically, CitH3-NETs activated GSDME in GSDMD-deficient Nlrp3 A350V macrophages, and GSDME deletion prevented pathology in Nlrp3 A350V -expressing GSDMD-deficient mice. In addition to this GSDME-dependent autoinflammation axis, PAD4 deletion also prevented autoinflammation in mice with neutrophil-specific Nlrp3 A350V expression that develop CAPS in a GSDMD-dependent manner. These observations support a CAPS model in which PAD4-mediated CitH3-NET release can trigger both GSDMD-dependent and GSDME-dependent autoinflammation.